Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brant A Inman

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 16, 2020
Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine studyWei Phin Tan, Andrew Chang, Steven C Brousell, et al.
BMC Cancer|October 8, 2010
Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancerLee W Jones, Pamela S Douglas, Neil D Eves, et al.
The Journal of Urology|May 24, 2019
Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter TrialYair Lotan, Brant A Inman, Leah Gerber Davis, et al.
Case Reports in Urology|January 11, 2021
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint InhibitorRyan S Chiang, Ashton A Connor, Brant A Inman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinomaXavier Frigola, Brant A Inman, Christine M Lohse, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 16, 2013
The impact of temperature and urinary constituents on urine viscosity and its relevance to bladder hyperthermia treatmentBrant A Inman, Wiguins Etienne, Rainier Rubin, et al.
Iscience|March 5, 2024
Multiomics profiling of urothelial carcinoma <i>in situ</i> reveals CIS-specific gene signature and immune characteristicsMeenakshi Anurag, Trine Strandgaard, Sung Han Kim, et al.
European Urology|August 14, 2016
Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder CancerThomas Longo, Kathleen F McGinley, Jennifer A Freedman, et al.
European Urology Oncology|February 21, 2023
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder CancerBrant A Inman, Noah M Hahn, Kelly Stratton, et al.
Urologic Oncology|February 21, 2026
Acute kidney injury following radical nephrectomy and inferior vena cava thrombectomy: A tertiary referral center experienceAlireza Ghoreifi, John V Dudinec, Michael C Ivey, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 16, 2020
Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine studyWei Phin Tan, Andrew Chang, Steven C Brousell, et al.
BMC Cancer|October 8, 2010
Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancerLee W Jones, Pamela S Douglas, Neil D Eves, et al.
The Journal of Urology|May 24, 2019
Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter TrialYair Lotan, Brant A Inman, Leah Gerber Davis, et al.
Case Reports in Urology|January 11, 2021
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint InhibitorRyan S Chiang, Ashton A Connor, Brant A Inman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinomaXavier Frigola, Brant A Inman, Christine M Lohse, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 16, 2013
The impact of temperature and urinary constituents on urine viscosity and its relevance to bladder hyperthermia treatmentBrant A Inman, Wiguins Etienne, Rainier Rubin, et al.
Iscience|March 5, 2024
Multiomics profiling of urothelial carcinoma <i>in situ</i> reveals CIS-specific gene signature and immune characteristicsMeenakshi Anurag, Trine Strandgaard, Sung Han Kim, et al.
European Urology|August 14, 2016
Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder CancerThomas Longo, Kathleen F McGinley, Jennifer A Freedman, et al.
European Urology Oncology|February 21, 2023
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder CancerBrant A Inman, Noah M Hahn, Kelly Stratton, et al.
Urologic Oncology|February 21, 2026
Acute kidney injury following radical nephrectomy and inferior vena cava thrombectomy: A tertiary referral center experienceAlireza Ghoreifi, John V Dudinec, Michael C Ivey, et al.
Pageof 16